Vita Life Sciences Limited (ASX:VLS)

Market Cap	133.10M +29.7%
Revenue (ttm)	93.27M +17.3%
Net Income	10.44M +18.8%
EPS	0.18 +16.2%
Shares Out	54.33M
PE Ratio	13.35
Forward PE	n/a
Dividend	0.14 (5.79%)
Ex-Dividend Date	Mar 27, 2026

Volume	20,245
Open	2.490
Previous Close	2.450
Day's Range	2.470 - 2.500
52-Week Range	2.150 - 2.840
Beta	0.50
Analysts	Hold
Price Target	0.85 (-66.0%)
Earnings Date	May 22, 2026

About Vita Life Sciences

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. Vita Life Sciences Limited was founded in 1947 and is headquartered in Mascot, Australia.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1947
• Employees: 350
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: VLS

Financial Performance

In 2025, Vita Life Sciences's revenue was 93.27 million, an increase of 17.31% compared to the previous year's 79.51 million. Earnings were 10.44 million, an increase of 18.80%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Jun 19, 2026

Data Sources Report a data error